John Sievenpiper
14
0
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction
Role: lead
Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk
Role: lead
Meta-analyses of Nuts and Risk of Obesity
Role: lead
Network Meta-analyses of Artificially Sweetened Beverages and Cardiometabolic Risk
Role: lead
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Role: lead
Meta-analyses of the Effect of Liquid Meal Replacements on Cardiometabolic Risk
Role: lead
Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease
Role: lead
Meta-analyses of Liquid Versus Solid Calories and Body Weight
Role: lead
Meta-analyses of the Effect of Legumes on Blood Pressure
Role: lead
Meta-analyses of Dietary Pulses and Cardiometabolic Risk
Role: lead
Meta-analyses of Fructose and Cardiometabolic Risk
Role: lead
Meta-analysis of Fructose-Containing Sugar Sweetened Beverages (SSBs) and Weight Change
Role: lead
Meta-analyses of the Effect of Dietary Pulses on Acute Postprandial Metabolic Control
Role: lead
Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome
Role: lead
All 14 trials loaded